Skip to main content
Premium Trial:

Request an Annual Quote

Canada, Spain to Create Joint Genomic-Research Funds

NEW YORK, May 13 - Canadian and Spanish genomic research foundations signed an agreement last week to fund joint large-scale research programs shared by the two countries.


The three-year agreement, signed by Genome Spain Foundation and Genome Canada, will focus on "larger and more difficult genomics projects," Canada's international trade minister Pierre Pettigrew said in a statement.


"Canada and Spain share a common interest in the development of genomics research," he said.


The two countries plan to promote exchange between researchers, biotechnology, pharmaceutical, and venture-capital firms in order to identify large-scale projects that may be conducted cooperatively.


Through the agreement, the two countries will launch a competitive grant program in 2003. Spanish venture capitalists also plan to attend the Quebec City BioContact conference in October 2002.


The Genome Spain Foundation was established last month. It is modeled on  Genome Canada, a non-profit genomic research foundation funded primarily through government money.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.